Bevacizumab vs Ranibizumab for Macular Edema Due to BRVOBevacizumab vs Ranibizumab for Macular Edema Due to BRVO

How does treatment between these two anti-VEGF agents compare in terms of visual acuity and central retinal thickness outcomes? The British Journal of Ophthalmology
Source: Medscape Ophthalmology Headlines - Category: Opthalmology Tags: Ophthalmology Journal Article Source Type: news